Supplementary Table S1 from A Phase II Trial of Dovitinib in BCG-Unresponsive Urothelial Carcinoma with <i>FGFR3</i> Mutations or Overexpression: Hoosier Cancer Research Network Trial HCRN 12-157
收藏NIAID Data Ecosystem2026-05-16 收录
数据链接:
官方服务:
资源简介:
Supplementary Table S1: All-Grade Toxicity
创建时间:
2017-06-15




